Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2014
03/20/2014US20140079707 Lox and loxl2 inhibitors and uses thereof
03/20/2014US20140079706 Combination therapy of antibodies against human csf-1r and uses thereof
03/20/2014US20140079705 Bispecific immunobinders directed against tnf and il-17
03/20/2014US20140079704 BI-Specific Diabodies For Masking And Targeting Vaccines
03/20/2014US20140079703 Combination therapies comprising anti-erbb3 agents
03/20/2014US20140079701 Linker peptides and polypeptides comprising same
03/20/2014US20140079699 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
03/20/2014US20140079698 Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancer
03/20/2014US20140079697 Humanized antibodies against monocyte chemotactic proteins
03/20/2014US20140079695 Preventive agent for vasculitis
03/20/2014US20140079692 Dosages for treatment with anti-egfr antibodies
03/20/2014US20140079691 Thermostable antibody framework regions
03/20/2014US20140079689 Fc VARIANTS AND METHODS FOR THEIR PRODUCTION
03/20/2014US20140079668 Targeted interferons demonstrate potent apoptotic and anti-tumor activities
03/20/2014US20140079665 Therapeutic anti-igf1r combinations
03/19/2014EP2708560A1 Antibody specifically recognising transferrin receptor
03/19/2014EP2708559A2 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
03/19/2014EP2708558A2 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
03/19/2014EP2708557A1 Method and compositions for inhibiting CD32B expressing cells
03/19/2014EP2708556A1 Pharmaceutical composition for the use in a combination therapy for prevention or treatment of C-Met or angiogenesis factor induced diseases
03/19/2014EP2708555A2 Polyclonal antibodies to cloned fungal polypeptide targets
03/19/2014EP2707495A1 Biochemical markers for cvd risk assessment
03/19/2014EP2707392A1 Monoclonal antibody for acetylamantadine
03/19/2014EP2707391A1 Antibodies against her3
03/19/2014EP2707390A1 Antibodies for treatment of cancer expressing claudin 6
03/19/2014EP2707389A2 Assay reagents for a neurogranin diagnostic kit
03/19/2014EP2707388A2 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
03/19/2014EP2707029A1 Methods of treating or preventing cholesterol related disorders
03/19/2014EP2707028A1 c-KIT ANTIBODIES AND USES THEREOF
03/19/2014EP2707023A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
03/19/2014EP2707020A1 Compositions and methods for treating cancer
03/19/2014CN1938046B Monomethylvaline compounds capable of conjugation to ligands
03/19/2014CN103649326A Antibody-like proteins for therapeutic and diagnostic use
03/19/2014CN103649125A Removal of target cells by circulating virus-specific cytotoxic t-cells using MHC class I comprising complexes
03/19/2014CN103649124A Bacterial host strain expressing recombinant dsbc
03/19/2014CN103649123A Antibodies against G-CSFR and uses thereof
03/19/2014CN103649122A Humanised anti-CD52 antibodies
03/19/2014CN103649121A Antibodies to ADP-ribosyl cyclase 2
03/19/2014CN103649120A Anti-CXCR4 antibody with effector functions and its use for the treatment of cancer
03/19/2014CN103649119A An antibody specifically binding to insulin-like growth factor-1
03/19/2014CN103649118A Bispecific binding agents
03/19/2014CN103649117A Fc variants and methods for their production
03/19/2014CN103649114A Novel immunoconjugates
03/19/2014CN103648529A Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at risk for potential adverse effects
03/19/2014CN103648525A Recombinant immunotoxin targeting mesothelin
03/19/2014CN103648523A Compositions and methods for treating cancer
03/19/2014CN103642792A Preparation and application of neutralizing monoclonal antibody of anti-hepatitis C virus
03/19/2014CN103642761A Respiratory syncytial virus-like particles and preparation method and application thereof
03/19/2014CN103642757A Bluetongue virus NS2 protein monoclonal antibody BTV-4D4, B cell epitope recognized thereby and applications
03/19/2014CN103641920A Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (PRRSV) and uses thereof
03/19/2014CN103641917A Anti-CD26 antibody and application thereof
03/19/2014CN103641916A Binding member for gm-csf receptor
03/19/2014CN103641915A Binding member for GM-CSF receptor
03/19/2014CN103641914A Monoclonal antibody of anti-human BTF (Bcl-2-associated transcription factor 1) and application thereof
03/19/2014CN103641913A Preparation method of hansenula polymorpha HCP (Host Cell Protein) antibody, prepared antibody and application thereof
03/19/2014CN103641912A Citric acid bacillus polyclonal antiserum, preparation method and application thereof in detection of salmonella
03/19/2014CN103641885A Protein purification by ion exchange chromatography
03/19/2014CN103638913A Bonding polysaccharide type hydrophilic chromatographic stationary phase as well as preparation method and application thereof
03/19/2014CN103638536A Molecular probe and preparation method and application thereof
03/19/2014CN103638521A Nerve elongation promoter and elongation inhibitor
03/19/2014CN102942629B Humanized antibody for resisting severe fever with thrombocytopenia syndrome bunyavirus (SFTSV)
03/19/2014CN102863527B Humanized hepatitis b virus resistance surface antigen gene engineering antibodies and preparation method and application thereof
03/19/2014CN102323415B Immunochromatography test paper for detecting Ciprofloxacin and preparation method thereof
03/19/2014CN102174541B Method for modifying plant morphology, biochemistry and physiology
03/19/2014CN101927011B Virus inactivation method for solution of globulin
03/19/2014CN101198698B Process for production of polypeptide by regulation of assembly
03/18/2014US8674083 Polypeptide variants with altered effector function
03/18/2014US8674082 Rationally designed antibodies
03/18/2014US8674079 Cancer cell migration and cancer cell invasion inhibitor
03/18/2014US8674078 Methods of using BTL-II proteins
03/18/2014US8674076 BSL2vcvc-lg polypeptides
03/18/2014US8674020 Process for preparing polyamides
03/18/2014US8673870 Combined DNA vaccine and biological modifiers for cancer therapy
03/18/2014US8673850 PCSK9 inhibitors and methods of use thereof
03/18/2014US8673652 Immunoassay with extended detection window
03/18/2014US8673593 Antibodies to alpha-synuclein
03/18/2014US8673583 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/18/2014US8673572 Methods used in identifying glioblastoma
03/18/2014US8673310 Stable and soluble antibodies inhibiting TNFα
03/18/2014US8673307 HIV-1 anti-core neutralizing antibodies that target a conformational epitope within the ALPHA5-helix of GP120
03/18/2014US8673305 Methods of treatment with antibodies against the extracellular loops of C5aR
03/18/2014US8673304 Humanized anti-CD4 antibody with immunosuppressive properties
03/18/2014US8673303 Cripto blocking antibodies and uses thereof
03/18/2014US8673300 Therapeutic compositions and methods for the prevention of autoimmune diseases
03/18/2014US8673299 Anti-RANTES antibodies
03/18/2014CA2767061C Specific binding agents of human angiopoietin-2
03/18/2014CA2703263C Immunosuppressive polypeptides and nucleic acids
03/18/2014CA2680945C Anti-pdgfralpha antibodies
03/18/2014CA2569788C Tumor specific antibody
03/18/2014CA2520671C Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
03/18/2014CA2496834C Method of treatment of asthma using antibodies to complement component c5
03/18/2014CA2481827C Polyvalent cation-sensing receptor in atlantic salmon
03/18/2014CA2355364C Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
03/18/2014CA1341637C Chemiluminescent acridinium salts
03/17/2014CA2827177A1 Polyclonal antibodies to cloned fungal polypeptide targets
03/13/2014WO2014040024A1 The use of antibodies in treating hiv infection and suppressing hiv transmission
03/13/2014WO2014039523A1 Multi-chain chimeric antigen receptor and uses thereof
03/13/2014WO2014039461A1 Methods for treating atopic dermatitis by administering an il-4r antagonist
03/13/2014WO2014039372A1 Antibodies which detect pivkaii and methods of use thereof
03/13/2014WO2014037899A2 Il-18 binding molecules
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 1494